Dr. Robert C. Sorenson, MD, PhD

Dr. Sorenson practices at Inland Eye Specialists Surgery Center - Hemet in Hemet, California.

Dr. Sorenson's NPI, 1366422917, was assigned on January 19, 2006. Dr. Sorenson graduated from University Of Michigan Medical School in 1997. Dr. Sorenson holds California license G86087.

Dr. Sorenson's primary practice is Inland Eye Specialists Surgery Center - Hemet, at 3953 West Stetson Avenue, Hemet, CA 92545. The practice phone is (951) 652-4343.

Dr. Sorenson's primary practice is Inland Eye Specialists Surgery Center - Hemet in Hemet, California. Dmand AI also links Dr. Sorenson to 1 medical group, named with a free account. Dr. Sorenson's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sorenson practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Sorenson's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Sorenson is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Sorenson's licenses on file in 2 states: California and Michigan.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Sorenson treats.

CMS data shows 1,652 Medicare services from Dr. Sorenson across 12 procedure codes in 2024, for 606 Medicare patients. Medicare paid $146,791 for them.

CMS counts 606 Medicare patients who saw Dr. Sorenson in 2024. The largest group is 75 to 84, with 228 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sorenson's median patient age at 68, with 60% women.

In 2024, Dr. Sorenson wrote 3,275 Medicare Part D claims for 798 patients. 66% of them were for generic drugs. CMS names the drug for 3,199 of them, across 28 drugs with 11 or more claims each, at $224,381 in total drug cost. In 2023, CMS named 2,805 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Sorenson for performance year 2024, reported as part of a group. Dr. Sorenson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 177 procedures of cataract surgery by Dr. Sorenson, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Sorenson in 2023. Dr. Sorenson's most frequent co-author is John A. Hovanesian, MD.

Dmand AI links Dr. Sorenson to 3 clinical trials. Conditions studied include Choroidal Effusions, Dry Eye Syndromes and Glaucoma, Open-Angle. Glaukos Corporation sponsors the most, 2. Open Payments lists research payments to Dr. Sorenson that name 1 trial.

CMS Open Payments shows 122 general payments to Dr. Sorenson from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 45% of the total. Glaukos Corporation paid the most, $2,427. It also lists 2 research payments totaling $1,866 from 2016 to 2018, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Sorenson, most recently CMS Stage 1 EHR in 2013.

Dr. Sorenson graduated from University Of Michigan Medical School in 1997. Dr. Sorenson is a member of AAO.

Dr. Sorenson is in network with 22 carriers, including Aetna, Elevance and Humana. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.